Trailing-twelve-month (TTM) revenue is $27.82 Million with a year-over-year growth of +135.52%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $3,083,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $3,235,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-07 |
| Q1 FY2026Period ended 2026-03-31 | $20,272,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-20 |
| Q2 FY2026Period ended 2026-06-30 | $1,225,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-19 |
| TTM revenue | $27,815,000 |
Current P/S: $2,475,236 market capitalization ÷ $27,815,000 TTM revenue = 0.09x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:50:14.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.23M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:52:04.756Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| License | N/A | N/A | N/A | N/A | $129,000 | $172,000 |
| Mytesi | $9M | $3M | $12M |
$27.82M
$27.82 Million
+135.52%
vs. $11.81M a year ago (TTM)
+31.88%
5 Year compound annual growth rate
1 Year
+135.52%
3 Year
+35.99%
5 Year
+31.88%
10 Year
+64.22%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $11.51M | ($178,000) | (1.52%) |
| 2024 | $11.69M | +$1.93M | +19.75% |
| 2023 | $9.76M | ($2.19M) | (18.36%) |
| 2022 | $11.96M | +$7.62M | +175.80% |
| 2021 | $4.33M | ($5.05M) | (53.81%) |
| 2020 |
TTM Growth
+135.52%
3-Year CAGR
+35.99%
5-Year CAGR
+31.88%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:52:04.756Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $10M |
| $11M |
| $11M |
| Neonorm | $76,000 | $62,000 | $48,000 | $42,000 | $28,000 | $35,000 |
|---|
| $9.38M |
| +$3.61M |
| +62.51% |
| 2019 | $5.78M | +$1.36M | +30.77% |
| 2018 | $4.42M | +$54,959 | +1.26% |
| 2017 | $4.36M | +$4.22M | +2981.61% |
| 2016 | $141,523 | ($116,858) | (45.23%) |
